|
| Exchange Disseminated Time | Natco Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 11, 2015, inter alia, to consider the unaudited financial Results for the quarter ended December 31, 2014 (Q3), to consider Interim Dividend, if any, for the financial year 2014-15 and related matters etc.
Further, the Trading Window for dealing in the securities of the Company will be closed from January 30, 2015 to February 13, 2015 (both days inclusive). Trading window will open on February 16, 2015. |
|
|